View this email in your browser

TrialStat News for March 2020

To our clients, partners, and industry friends,

Providing high quality, reliable solutions and services, combined with uninterrupted support of our sponsors and partners in the management of their clinical research programs, has always been TrialStat’s primary focus.

With strong corporate guidance, a high degree of caution in our business practices both at home and abroad, and well-informed advanced preparations, the TrialStat team is continuing operations at full capacity despite the recent and ongoing challenges associated with the COVID-19 virus.

As World Health Organizations continue their efforts to battle Covid-19, we here at TrialStat are doing our part to ensure the safety of our team and those around us. Working remotely, we continue to support our Sponsors and Partners as our entire industry works to ensure the safety of participants, health care workers, and research teams along with the integrity of the studies and their data.

Upcoming Events and Meetings

We have limited our travel for the foreseeable future until the situation is in hand and travel restrictions are lifted, however we have expanded our team’s abilities to engage remotely and look forward to connecting with you from afar until the situation is resolved.

Many industry events such as HIMMS have been cancelled, and we continue to monitor the situations for various upcoming meetings. DIA 2020 so far remains unchanged, and while we are currently planning to attend as usual, we will revisit this decision as further information becomes available.

From the entire TrialStat team, we wish you and yours good health as our industry and our communities work together to navigate this outbreak over the coming weeks and months.

Chris Hamelin
Business Unit Head
TrialStat Solutions Inc.

McMaster Innovation Park acquires Hamilton Spectator building

The Hamilton Spectator building will soon become a hub for emerging life sciences companies.

McMaster Innovation Park is the new owner of The Spectator building at 44 Frid St., the newspaper’s home since 1976.

MIP plans to convert the building into a state-of-the-art hub complete with labs and office space for emerging life sciences companies.

The redeveloped Spectator building will be part of a growing MIP campus that will eventually take up much of the property between Frid Street, Highway 403 and Aberdeen Avenue.

When it’s completed, the MIP campus will employ 5,000 people and span 2.5 million square feet of space, about the same as downtown Toronto’s First Canadian Place skyscraper.

Continue Reading The Press Release

Medicine By Design – New Ideas Awards 2020

"The 2020 Medicine by Design New Ideas Awards will focus on seeding new ideas that have strong potential to advance regenerative medicine research. Each funded project will receive up to $100,000 per year for a two-year period from July 1, 2020, to June 30, 2022.

Proposed projects must align with at least one of the Medicine by Design priority areas: 1) developing cell therapies to cure disease; 2) finding new approaches to promote endogenous repair and regeneration; 3) accelerating the path from basic research to clinical application; 4) addressing long-standing fundamental questions in regenerative medicine; or 5) minimizing tissue dysregulation or degeneration."

Continue Reading Article

Build Your Neurotech Venture with The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program!

“The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program is Canada’s single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures.

Application for the 2020 ONtrepreneurs Competition is NOW OPEN!“

Continue Reading Article

A New Paradigm in Data Management Technology

Learn More About TrialStat